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INTRODUCTION
The most severe acute hemolytic transfusion reactions
(HTRs) occur when transfused packed red blood cells (RBCs)
are incompatible with serum ABO blood group of the recip-
ient (1). Such HTRs with severity also are associated with
unexpected antibodies (1, 2). We report a case of two consec-
utive episodes of acute HTRs due to multiple alloantibodies
including anti-E, anti-c and anti-Jkb in a 34-yr-old man who
received repeated transfusions after total hip replacement.
CASE REPORT
A 34-yr-old man who suffered from hematuria and fever
was admitted to the Emergency Department of Pusan Nation-
al University Hospital on 7 December 2002, after repeated
transfusions of packed RBCs. Total hip replacement was per-
formed at a local orthopedic clinic on 26 November 2002 for
treatment of avascular necrosis of left femoral head. He received
five units of packed RBCs during the surgery. An unexplained
drop in hemoglobin level was observed nine days after the
surgery. He was transfused with packed RBCs; however, dur-
ing the transfusion of the first two units, fever and brown-col-
ored urine were resulted, and the transfusion was discontin-
ued. Transfusion of RBCs was performed again the next day.
He experienced even more severe symptoms during the trans-
fusion of the first unit, and therefore the transfusion was sto-
pped and the patient was transferred to Pusan National Uni-
versity Hospital. Vital signs were as follows: blood pressure
110/70 mmHg, pulse rate 80/min, temperature 36℃, and
respiration rate 20/min. Physical examination revealed no re-
markable abnormal findings except icteric sclera. Complete
blood cell count showed leukocyte count of 6,400/ L, hemo-
globin level of 8.8 g/dL, and platelet count of 22,000/ L. Blood
chemistries yielded abnormal results: total bilirubin 2.46 mg/
dL (reference range 0.3-1.3 mg/dL), direct bilirubin 1.16 mg/
dL (reference range 0.05-0.40 mg/dL), aspartate aminotrans-
ferase 44 IU/L (reference range 15-40 IU/L), alanine amino-
transferase 34 IU/L (reference range 6-40 IU/L), alkaline phos-
phatase 146 IU/L (reference range 95-280 IU/L), BUN 14
mg/dL (reference range 6-26 mg/dL), creatinine 1.2 mg/dL
(reference range 0.4-1.5 mg/dL), and lactate dehydrogenase
1,251 IU/L (reference range 218-472 IU/L). The results of
ABO and RhD blood grouping showed group O and RhD
positive. The antibody screening test (DiaMed AG, Cressier,
Morat, Switzerland) produced positive results. Anti-E, anti-
c and anti-Jkb were detected by antibody identification study
(Table 1); however, the result was negative on repeated direct
antiglobulin tests. Kidd and Rhesus antigenic phenotyping
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Acute Hemolytic Transfusion Reactions due to Multiple Alloantibodies
Including Anti-E, Anti-c and Anti-Jk
b
We report a case of two consecutive episodes of acute hemolytic transfusion reac-
tions (HTRs) due to multiple alloantibodies in a 34-yr-old man who suffered from
avascular necrosis of left femoral head. He received five units of packed red blood
cells (RBCs) during surgery. Then the transfusion of packed RBCs was required
nine days after the surgery because of the unexplained drop in hemoglobin level.
The transfusion of the first two units resulted in fever and brown-colored urine, but
he received the transfusion of another packed RBCs the next day. He experienced
even more severe symptoms during the transfusion of the first unit. We performed
antibody screening test, and it showed positive results. Multiple alloantibodies includ-
ing anti-E, anti-c and anti-Jk
b were detected by antibody identification study. Acute
HTRs due to multiple alloantibodies were diagnosed, and the supportive cares were
done for 6 days. We suggest the antibody screening test should be included in the
panel of pretransfusion tests for safer transfusion, and it is particularly mandatory
for the patients with multiple transfusions, pregnant women, and preoperative pa-
tients.
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(DiaMed AG) were conducted; it showed Jka positive, Jkb
negative on Kidd antigenic phenotyping, and Rhesus sub-
group was CDe. The haptoglobin level was below the detec-
tion limit (<10.0 mg/dL).
He was diagnosed as having acute HTRs due to multiple
alloantibodies including anti-E, anti-c and anti-Jkb. No more
transfusions were requested, and he was under the supportive
care for 6 days. He returned to the previous hospital with relief
of symptom, and his condition gradually improved thereafter
(Fig. 1).
DISCUSSION
Acute HTRs are most severe when these occur in ABO
incompatibility (1). They also are associated with unexpected
antibodies to the other blood group antigens (1, 2). The bind-
ing of antibody to blood group antigens may activate comple-
ment and intrinsic clotting cascade of coagulation system and
causes intravasucular hemolysis, or may be phagocytozed by
macrophages in reticuloendothelial system, which results in
extravascular hemolysis (2). Also, the role of cytokines in acute
HTRs is increasingly recognized (1, 2). The symptoms and
signs produced by acute HTRs include fever, hematuria, jaun-
dice, renal failure, and even the state of shock. The reports of
acute HTRs related to unexpected antibodies including anti-
bodies against Rhesus, Kidd, Diego, P antigens, and others
have been introduced in the literature (3-8).
The patient reported having received the transfusion of
packed RBCs during the surgery of right knee twelve years
before. Thus, we think that the delayed HTR might have
occurred mainly due to anti-E, known as the most common
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Table 1. The results of antibody screening and identification test (DiaMed AG, Screening cell Lot No. Set I+II 45151.16.x and 05980.85.x:
Panel cell Lot No. SetID-Diapanel 45161.17.x)
*LISS, low ionic strength salt solution; nt, not tested.
Fig. 1. The changes of laboratory results after acute hemolytic trans-
fusion reactions.
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causative antibody in delayed HTRs, with or without the
other unexpected antibodies, after receiving the transfusion
of the five units of packed RBCs during the operation; how-
ever, no antibody screening test was performed for detection
of unexpected antibodies. First acute HTR was noticed when
the patient was transfused with the two units of packed RBCs
nine days after the replacement surgery, and he complained
of fever and brown-colored urine concomitantly. Unfortunately,
no further evaluation was done for hemolytic reaction, and
he was transfused again with one unit of packed RBCs the
day after. Then the second acute hemolytic episode with even
more severe symptoms and signs such as fever, hematuria, and
jaundice occurred. In addition, severe thrombocytopenia was
observed immediately upon admission, probably accompanied
by the activation of coagulation system during the acute HTR.
However, no further evaluation was done for any other partic-
ular coagulopathies.
Anti-E, anti-c and anti-Jkb were detected by a series of anti-
body identification tests (DiaMed AG), such as antiglobulin
and enzyme phase. In general, direct antiglobulin test reveals
positive in HTR, but the result in this case was negative prob-
ably due to immediate and aggressive destruction of transfused
red cells by multiple alloantibodies. In Korea, pretransfusion
tests including ABO, RhD blood grouping and crossmatch-
ing test for safe transfusion have been performed for many years.
The primary purpose of the crossmatching is to detect ABO
incompatibility, and the secondary purpose of this test is to
exclude incompatible donor cells with patient serum (i.e. detec-
tion of unexpected antibodies). Antibodies reactive at 37℃
or in the antiglobulin test are more likely to be clinically sig-
nificant than cold reactive antibodies (2). Unfortunately, an-
tiglobulin phase of crossmatching in order to rule out the unex-
pected antibodies have not been conducted by many hospi-
tals other than university-affiliated medical centers in Korea.
Hence, the clinically significant unexpected antibodies such
as antibodies against Rhesus, Kidd, Duffy, Diego antigens,
and others cannot be detected by saline phase of crossmatch-
ing alone.
The antibody screening test is used as a part of routine pre-
transfusion studies for the purpose of detection of unexpected
antibodies; however, in Korea it has not received as much
attention as such a tool prior to transfusion. According to the
annual reports by The Korean Association of Quality Assurance
for Clinical Laboratory published in 2002, hospitals with ability
to perform antibody screening tests have been gradually
increasing in number for the past 3 or 4 yr as column agglu-
tination method was introduced, presenting up to 42.1% of
the laboratories participated (9). However, the number of hos-
pitals that actually perform this test as part of their routine
pretransfusion study is quite limited. For preventing HTRs
due to unexpected antibodies, antiglobulin phase of cross-
matching or antibody screening test must be conducted in
all patients who receive transfusion. Thus, we suggest the
antibody screening test should be included in the panel of
pretransfusion tests for safer transfusion, which is already a
part of routine pretransfusion procedure in other countries. In
addition, it is needed to make it mandatory for patients with
multiple transfusion and pregnant women as well as preop-
erative patients.
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